[1]王任飞,谭建.血管腔内近距离照射预防介入治疗后再狭窄的研究现状[J].国际放射医学核医学杂志,2001,25(4):153-157.
　WANG Ren-fei,TAN Jian.Current study of intravascular brachytherapy preventing restenosis after interventional therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(4):153-157.
点击复制

血管腔内近距离照射预防介入治疗后再狭窄的研究现状(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
25
期数:
2001年第4期
页码:
153-157
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
Current study of intravascular brachytherapy preventing restenosis after interventional therapy
作者:
王任飞;  谭建
300052 天津, 天津医科大学总医院核医学科
Author(s):
WANG Ren-fei;  TAN Jian
Department of Nuclear Medicine, General Hospital of TianJin Medical University, Tianjin 300052, China
关键词:
放射性核素; 近距离照射; 血管成形术; 再狭窄
Keywords:
radionuclide; brachytherapy; angioplasty; restenosis
分类号:
R817.5
摘要:
血管成形术后发生再狭窄影响手术的远期疗效。血管腔内近距离照射治疗可有效抑制血管内膜的过度增生,促进细胞凋亡,同时还可引起管壁正性重建,增加管腔面积。大量的临床资料证实,该方法有效且安全可行,是介入心脏病学的一大突破。
Abstract:
Restenosis after angioplasty influences the long-dated surgical effect. Intravascular brachy-radiotherapy can effectively inhibit neointima proliferation and induce cell apoptosis. At the same time it may contribute to positive remodeling and a larger vessel perimeter. Many results of clinical trials proved that brachytherapy was effective, safe and feasible for clinical use. It is a great success of interventional cardiology.

参考文献/References:

[1] Waksman R, Rodriguez Y.Effect of intravascular ir-radiation on cell proliferation, apoptosis, and vascular remodelling after balloon overstretch injury of porcine coronary arteries[J].Circulation, 1997, 96:1944-1952.
[2] Hehrlein C, Kovacs A.A novel balloon angioplasty catheter impregnated with beta-particle emitting ra-dioisotopes for vascular brachytherapy to prevent restenosis[J].Eur Heart J, 2000, 21(24):2056-2062.
[3] Liermann DD, Bauernsachs R.Five year follow-up af-ter brachytherapy for restenosis in peripheral arteries[J].Semin Interv Cardiol, 1997, 2(2):133-137.
[4] Verin V, popowski Y.Intraarterial beta irradiationin-duces smooth muscle cell apoptosis and reduces medialcel lularity in a hypercholesterolemic rabbit restenosis model[J].Int J Radiat Oncol Biol Phys, 2000, 46(3):661-670.
[5] Verin V, Urban P.Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty[J].Circulation, 1997, 95(5):1138-1144.
[6] Hehrlein C.Low-dose radiactive endovascular stents prevent smooth muscle cell proliferation and neointi-mal hyperplasiain rabbits[J].Circulation, 1995, 92(6):1570-1575.
[7] Hehrlein C.Pure beta-particle-emitting stents inhibit, neiintima formation in rabbits[J].Circulation, 1996, 93(4):641-645.
[8] Farb A, Tang AL, Virmani R, et, al.Neointima is re-duced but endothelialization is incomplete 3 months after 32P beta-emitting stent placement[J].Circulation, 1998, 98:I-779.
[9] Taylor AJ, Gorman PD.Differential effect of 32P beta particle-emitting stents on the neointima and adventitia in the dog model[J].Circulation, 1998, 98:I-779.
[10] Mazur W.High dose rate intracoronary radiation for inhibition of neointima formation in the stented and balloon-injured porcine model of restenosis:angio-graphic, morphomitric, and histopathologic analyses[J].Int J Radiat Oncol Biol Phys, 1996, 36:777-788.
[11] Condado.Three year clinical and angiographic follow-up after ICRT with 192Ir[J].Circulation, 1998, I-abstr.
[12] Waksman R, White LR, Chan RC, et al.Intracoro-nary γ-radiation therapy after angioplasty inhibits re-currence in patients with in-stent restenosis[J].Circulation 2000, 101:2165-2171.
[13] Waksman R, Porrazo MS, Chan RC, et al.Results from the ARTISTIC feasibility study of 192Ir gammaradiation to prevent recurrence of In-stent restenosis[J].Circulation, 1998, 98:I-442.
[14] Akiyama T, Moussa I, Reimers B, et al.Angiograph-ic and clinical outcome following coronary stenting ofsmall coronary stenting of small vessles:a compari-sion with coronary stenting of large vessles[J].J Am Coll Cardial, 1998, 32:1610-1618.
[15] Verin V, Urban P, Popowski Y, et al.Feasibility of intracoronary beta-irradiation to reduce restenosis af-ter balloon angioplasty:a clinical pilot study[J].Cir-culation, 1997, 95:1138-1144.
[16] King SBIII, Crocker IR, Waksman R, et al.Coro-nary endovascular beta-radiation for restenosis using anovel catheter system:initial clinical feasibility study[J].Circulation, 1996, 94(supplⅠ):I-619.
[17] King SB.Endovascular beta radiation to reduce restenosis after coronary balloon angioplasty:results of the beta energy restenosis trial (BERT)[J].Circu-lation, 1998, 97:2025-2030.
[18] Sirnes PA, Golf S, Myreng Y, et al.Sustained benefit of stenting chronic coronary occlusion:long-term clin-ical follow-up of the Stenting in Chronic Coronary Oc-clusion (SICCO) study[J].J Am Coll Cardiol, 1998, 32(2):305-310.
[19] Silber S, von Rottkay P, Lossl P, et al.Safety and feasibility of intracoronary brachytherapy with the Novoste system within the scope of international mul-ticenter studies[J].Z Kardiol, 2000, 89(4):323-329.
[20] Raizner AE, Oesterle S, Waksman R, et al.The PRE-VENT trial, a feasibility study of intracoronary brachytherapy in the prevention of restenosis:an in-terim report[J].Circulation, 1998, 98:I-651.
[21] Coen V L, Knook AH, Wardeh AJ, et al.Endovascu-lar brachytherapy in coronary arteries:the Rotlerdam experience[J].Cardiovasc Radiat Med, 2000, 2(1):42-50.
[22] Mews GC, Fox R, Cope G, et al.Rhenium 188 liquid filled balloon for the treatment of intracoronary in-stent restenosis:a 26 patient pilot study[J].Cardio-vasc Rad Ther Ⅲ.Washington DC, 1999, 23(abstr).
[23] Albiero R, Colombo A.European high-activity 32P ra-dioactive stent experience[J].J Invasive Cardiol, 2000, 12(8):416-421.
[24] Albiero R, Adamian M.Results of the Milan BX dose response study on 32P radioactive beta-emitting stent implantation in patients with CAD[J].Cardiovasc Rad TherⅢ, Washington DC, 1999:391-392.

相似文献/References:

[1]郑玉明.敷贴治疗寻常型银屑病的疗效分析[J].国际放射医学核医学杂志,2015,39(4):300.[doi:10.3760/cma.j.issn.1673-4114.2015.04.006]
　Zheng Yuming.Clinical effectiveness of applicator brachytherapy for psoriasis vulgaris[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):300.[doi:10.3760/cma.j.issn.1673-4114.2015.04.006]
[2]万建美,范我.动脉粥样硬化斑块核素显像研究进展[J].国际放射医学核医学杂志,2007,31(1):17.
　WAN Jian-mei,FAN Wo.The progress of research on atherosclerotic plaque nuclear imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):17.
[3]陈立波,朱瑞森.NIS在肿瘤核素基因显像与治疗中的应用研究[J].国际放射医学核医学杂志,2005,29(2):70.
　CHEN Li-bo,ZHU Rui-sen.Progress of application study on sodium/iodide symporter as a radionuclide imaging and therapeutic gene[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):70.
[4]刘彧.放射性核素在关节炎治疗中的应用[J].国际放射医学核医学杂志,2003,27(2):59.
　LIU Yu.The application of radionuclide therapy in arthritis[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):59.
[5]法逸华.125I粒子近距离照射在肿瘤治疗中的应用[J].国际放射医学核医学杂志,2003,27(3):115.
　FA Yi-hua.Brachytherapy with 125I seeds for the treatment of tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):115.
[6]陈建伟.放射性核素近距离治疗血管再狭窄的现状和进展[J].国际放射医学核医学杂志,2002,26(3):97.
　CHEN Jian-wei.The status quo and progress of radionuclides for intravascular brachytherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(4):97.
[7]欧晓红.放射性核素反义治疗[J].国际放射医学核医学杂志,2002,26(6):246.
　OU Xiao-hong.Radionuclide antisense therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(4):246.
[8]秦光明.肿瘤核素反义显像技术的研究现状与展望[J].国际放射医学核医学杂志,2001,25(5):213.
　QIN Guang-ming.Current researches and prospective of radiolabeled antisense imaging in tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(4):213.
[9]赵晋华,林祥通.抑郁症的放射性核素脑血流灌注和脑受体显像研究进展[J].国际放射医学核医学杂志,1998,22(2):49.
[10]诸洪达,陆梅,朱昌寿.食入放射性核素所致内照射剂量研究现状及展望[J].国际放射医学核医学杂志,1998,22(3):130.

备注/Memo

备注/Memo:
收稿日期:2001/4/11。
作者简介:王任飞(1977-),女,山西寿阳人,天津医科大学总医院核医学科硕士研究生;谭建(1957-),男,天津人,天津医科大学总医院核医学科主任医师,主要从事核素治疗研究。
更新日期/Last Update: 1900-01-01